These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16253950)

  • 1. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
    Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
    Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
    Shi J; Yan WW; Qi XR; Yang L; Zhang L
    Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol.
    Qi XR; Yan WW; Shi J
    World J Gastroenterol; 2005 Aug; 11(32):4947-52. PubMed ID: 16124043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of soybean-derived sterylglucoside and amphipathic polyethylene glycol on the cellular delivery and anisotropy of different cationic liposomes].
    Yan W; Fei R; Wang W; Qi X; Wei L; Cong X; Wang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):324-8. PubMed ID: 12914258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
    Shi J; Qi XR; Yang L; Fei R; Wei L
    Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
    Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
    J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
    Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
    J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
    Shimizu K; Maitani Y; Takayama K; Nagai T
    Biol Pharm Bull; 1997 Aug; 20(8):881-6. PubMed ID: 9300135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
    Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
    Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
    Zhang Y; Qi XR; Gao Y; Wei L
    Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
    Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
    J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
    Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
    Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.
    Ko YT; Bhattacharya R; Bickel U
    J Control Release; 2009 Feb; 133(3):230-7. PubMed ID: 19013203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
    Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
    J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cationic liposomes enhance the inhibitory effects of antisense oligodeoxynucleotide on hepatitis B virus].
    Yan W; Qi X; Wei L; Fei R; Wang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):629-33. PubMed ID: 14710259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.
    Weecharangsan W; Opanasopit P; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
    Curr Pharm Biotechnol; 2014; 15(9):790-9. PubMed ID: 25307014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition.
    Nakamura N; Hart DA; Frank CB; Marchuk LL; Shrive NG; Ota N; Taira K; Yoshikawa H; Kaneda Y
    J Biochem; 2001 May; 129(5):755-9. PubMed ID: 11328598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
    Shimizu K; Qi XR; Maitani Y; Yoshii M; Kawano K; Takayama K; Nagai T
    Biol Pharm Bull; 1998 Jul; 21(7):741-6. PubMed ID: 9703260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.